Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Explore the Innovation Trends Shaping Tomorrow’s Investment Landscape (click to learn more)
Sekur Private Data Advances Defense-Grade Secure Communications Platform (click to learn more)
Sorrento Resources Ltd. Intersects 33m of 2.12% TREO, Bottom Brook, Newfoundland (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Biotechnology
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (OTCID:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1540)
•••
Duster340
X
Post by
Duster340
on Feb 09, 2024 10:04am
Picked up
12K on sale this morning @92.5. we know we will be back above $1 before the end of march with the announcement of P2, management also thinks so thats why the warrant extension. , will
...more
(128)
•••
MrMugsy
X
Comment by
MrMugsy
on Feb 05, 2024 5:44pm
RE:RE:RE:RE:Page 44
Making a 3-day and a 7-day to accompany the 5-day is the initial confirmation of what's possbile with blister packs. This can then be tailored in the future for other things. What they need
...more
This micro-cap stock is leading the US graphite revolution
posted May 14, 2026 9:00am by
Graphite One Inc.
-
|
Graphite Creek’s estimated annual production is expected to average 175,000 tons of graphite concentrate and 256,000 tons of graphite and carbon products over the next two decades, figures whose importance requires context to be fully felt. Here are two ways to visualize how the project will impact the US industrial landscape.. ...read more
(55)
•••
Harper75
X
Comment by
Harper75
on Feb 05, 2024 2:01pm
RE:RE:RE:Page 44
When do you see strategy confirmation? Along with Phase 2 read-out? Would be nice for the market to see the potential the way you do..we do..
(128)
•••
MrMugsy
X
Comment by
MrMugsy
on Feb 04, 2024 8:04pm
RE:RE:Page 44
I am !!!! Let's find a manageable chronic path (daily dosing) - either full-chronic or chronic flare-up only (or both) ... with low-dose and placebo pills in the blister to protect the liver as
...more
(55)
•••
Harper75
X
Comment by
Harper75
on Feb 04, 2024 6:02pm
RE:Page 44
Are you seeing an Aspirin angle??
(128)
•••
MrMugsy
X
Post by
MrMugsy
on Feb 03, 2024 6:10pm
Page 44
Check out Page 44 of the presentation. Does anyone see something interesting calling out to us ?
(1540)
•••
Duster340
X
Post by
Duster340
on Feb 01, 2024 10:54am
6.4M warrants
outstanding down from 6.5M only 100k converted. i am surprised as the stock went as high as $1.13 they are trying hard to raise some cash, looks like the (sp) is not going to make a run up
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 01, 2024 7:00am
New Press Release - Antibe Extends Early Warrant Exercise Incentive Program
Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, is extending the Early Warrant Exercise Incentive Program (“Early Warrant Exercise Program”) for its 6.4...
read article.
(1540)
•••
Duster340
X
Post by
Duster340
on Jan 30, 2024 3:34pm
History repeats itself
on febuary/17/2021 ATE anounnces a bought deal with canaccord in febuary/?/2024 will ATE anounnce a bought deal with canaccord P2 begins march/2019 P2 begins march/2024
(1)
•••
Pronorvista
X
Post by
Pronorvista
on Jan 30, 2024 2:19pm
Ate
Canacoord cleans non-belivers every day good job .
(1540)
•••
Duster340
X
Post by
Duster340
on Jan 30, 2024 9:56am
No Insider Buying
very close to blackout period. the stock is magicaly back around the $1 mark, just some observations lol
(11)
•••
Benedictus
X
Comment by
Benedictus
on Jan 30, 2024 12:46am
RE:RE:RE:RE:RE:also 🚩
Thanks Mugs, appreciate your perspective as always. Should be an exciting year!
(1540)
•••
Duster340
X
Comment by
Duster340
on Jan 29, 2024 11:49pm
RE:ATE ( reading on ceo.ca
that is write and as i recall they dumped within a week of the financing and ATE (sp) took a big hit.
(1)
•••
Pronorvista
X
Comment by
Pronorvista
on Jan 29, 2024 9:11pm
RE:RE:ATE ( reading on ceo.ca
Currently we have a discount of $5 per share with much more potential .
(1)
•••
Pronorvista
X
Comment by
Pronorvista
on Jan 29, 2024 7:54pm
RE:ATE ( reading on ceo.ca
TORONTO — (February 24, 2021) – Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX:ATE) today announced that it has closed its previously announced bought deal public offering of 6,727,500
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
MindBio Develops Fatigue Prediction Model using Speech Analytics and AI
Podcasts